Cargando…

Effects of Liver Fibrosis on Islet Function in Patients with Chronic Hepatitis B Complicated with Impaired Fasting Glucose

BACKGROUND: Patients with chronic hepatitis B (CHB) and cirrhosis often have impaired fasting glucose (IFG). This study sought to investigate the impact of liver fibrosis on islet function in individuals diagnosed with CHB and IFG. MATERIAL AND METHODS: Patients with chronic hepatitis B (CHB) and im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yan, Gou, Wei, Zhang, Hai Feng, Li, Yi Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640824/ https://www.ncbi.nlm.nih.gov/pubmed/38021063 http://dx.doi.org/10.2147/IJGM.S429455

Ejemplares similares

Impaired Fasting Glucose in Cystic Fibrosis
por: Frohnert, Brigitte I., et al.
Publicado: (2010)

Quantification of liver fibrosis in chronic hepatitis B virus infection
por: Jieanu, CF, et al.
Publicado: (2015)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Chronic hepatitis B virus and liver fibrosis: A mathematical model
por: Friedman, Avner, et al.
Publicado: (2018)

Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients
por: Yao, Qun-Yan, et al.
Publicado: (2020)

Determinants of developing diabetes mellitus and vascular complications in patients with impaired fasting glucose
por: Sharifi, Faranak, et al.
Publicado: (2013)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020)

Racial/Ethnic Differences in Association of Fasting Glucose–Associated Genomic Loci With Fasting Glucose, HOMA-B, and Impaired Fasting Glucose in the U.S. Adult Population
por: Yang, Quanhe, et al.
Publicado: (2010)

Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Liu, Jianxue, et al.
Publicado: (2016)

Genetic Polymorphism of CYP27B1-1260 as Associated With Impaired Fasting Glucose in Patients With Chronic Hepatitis C Undergoing Antiviral Therapy
por: Sun, Derong, et al.
Publicado: (2016)

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Heo, Ja Yoon, et al.
Publicado: (2018)

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
por: Cho, Hyo Jung, et al.
Publicado: (2014)

Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B
por: HUANG, RENGANG, et al.
Publicado: (2016)

APRI Score as a Predictor of Significant Liver Fibrosis in Chronic Hepatitis B
por: Ayed, Houda Ben, et al.
Publicado: (2017)

Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Predictive Performances of Blood Parameter Ratios for Liver Inflammation and Advanced Liver Fibrosis in Chronic Hepatitis B Infection
por: Ding, Rongrong, et al.
Publicado: (2021)

Islets and Glucose Homeostasis
por: Chang, Tien-Jyun, et al.
Publicado: (2015)

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B
por: Poynard, Thierry, et al.
Publicado: (2011)

Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection
por: Trembling, P M, et al.
Publicado: (2014)

RDW-SD is Superior to RDW-CV in Reflecting Liver Fibrosis Stage in Patients with Chronic Hepatitis B
por: Yang, Kai, et al.
Publicado: (2023)

RE: Liver Shear-Wave Velocity to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Ozturker, Coskun, et al.
Publicado: (2016)

Fc receptor-like 5 gene polymorphisms and mRNA expression are associated with liver fibrosis in chronic hepatitis B
por: Yang, Jiajia, et al.
Publicado: (2022)

Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
por: Kanat, Mustafa, et al.
Publicado: (2012)

The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B
por: Zhang, Qingqing, et al.
Publicado: (2021)

Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016)

Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018)

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
por: Zeremski, Marija, et al.
Publicado: (2014)

A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B
por: Chen, Yaqiong, et al.
Publicado: (2020)

The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B
por: Zhong, Li‐Kun, et al.
Publicado: (2020)

Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection
por: Xiong, Ming, et al.
Publicado: (2019)

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
por: Liu, Ta-Wei, et al.
Publicado: (2020)

Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism
por: Mandelbaum, Amitai D., et al.
Publicado: (2012)

A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B
por: Chen, Yan, et al.
Publicado: (2019)

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir
por: Liu, Yi-Qi, et al.
Publicado: (2023)

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B
por: Li, Min-ran, et al.
Publicado: (2016)

Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells
por: Wang, Xingqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5tmir5uamakv3rk8971t83ngig